Beginning Oct. 1, CMS will provide hospitals with additional device reimbursement when a single-use duodenoscope is used for eligible cases of endoscopic retrograde cholangiopancreatography procedures in the hospital inpatient setting.
The add-on is applicable to Boston Scientific’s Exalt Model D Single-Use Duodenoscope, a device designed to eliminate infections caused by ineffective reprocessing of reusable duodenoscopes.
The Exalt Model D Single-Use Duodenoscope was granted transitional pass-through payment by CMS in 2020, allowing for incremental device reimbursement for cases performed in the hospital outpatient setting.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.